Retinal dystrophies (RDs) lead to irreversible vision impairment with no radical treatment. Although photoreceptor cells (PRCs) differentiated from human induced pluripotent stem cells (iPSCs) are essential for the study of RDs as a scalable source, current differentiation methods for PRCs require multiple steps. To address these issues, we developed a method to generate PRCs from human iPSCs by introducing the transcription factors, CRX and NEUROD1. This approach enabled us to generate induced photoreceptor-like cells (iPRCs) expressing PRC markers. Single-cell RNA sequencing revealed the transcriptome of iPRCs in which the genes associated with phototransduction were expressed. Generated iPRCs exhibited their functional properties in calcium imaging. Furthermore, light-induced damage on iPRCs was inhibited by an antioxidant compound. This simple approach would facilitate the availability of materials for PRC-related research and provide a useful application for disease modeling and drug discovery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938283 | PMC |
| http://dx.doi.org/10.1016/j.isci.2022.103987 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Photoreceptor-Like Signal Transduction Between Polymer-Based Protocells.
Adv Mater
November 2024
Department of Chemistry, University of Basel, Basel, 4002, Switzerland.
Deciphering inter- and intracellular signaling pathways is pivotal for understanding the intricate communication networks that orchestrate life's dynamics. Communication models involving bottom-up construction of protocells are emerging but often lack specialized compartments sufficiently robust and hierarchically organized to perform spatiotemporally defined signaling. Here, the modular construction of communicating polymer-based protocells designed to mimic the transduction of information in retinal photoreceptors is presented.
View Article and Find Full Text PDFPolymer-Based Nanoparticles with Probucol and Lithocholic Acid: A Novel Therapeutic Approach for Oxidative Stress-Induced Retinopathies.
Mol Pharm
July 2024
The Biotechnology and Drug Development Research Laboratory, Curtin Medical School & Curtin Health Innovation Research Institute, Curtin University, Bentley, Perth, Western Australia 6102, Australia.
Oxidative stress is pivotal in retinal disease progression, causing dysfunction in various retinal components. An effective antioxidant, such as probucol (PB), is vital to counteract oxidative stress and emerges as a potential candidate for treating retinal degeneration. However, the challenges associated with delivering lipophilic drugs such as PB to the posterior segment of the eye, specifically targeting photoreceptor cells, necessitate innovative solutions.
View Article and Find Full Text PDFMIR96 Has Good Potential to Differentiate Human Bone Marrow-Derived Mesenchymal Stem Cells into Photoreceptor-Like Cells.
Exp Clin Transplant
February 2024
From the Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Article Synopsis
- MicroRNAs, like MIR96, help brain cells develop and function, especially in the eyes, which is important for vision.
- Researchers added a MIR96 mimic to special cells from human bone marrow to see how it helps these cells turn into eye cells.
- The study found that after 24 and 48 hours, these cells showed signs of becoming photoreceptor cells, suggesting that using MIR96 might help treat eye diseases.
Allele-specific antisense oligonucleotides for the treatment of BEST1-related dominantly inherited retinal diseases: An in vitro model.
Exp Eye Res
April 2024
Hacettepe University, Faculty of Medicine, Department of Medical Genetics, Turkey. Electronic address:
Retinal dystrophies are a common health problem worldwide that are currently incurable due to the inability of retinal cells to regenerate. Inherited retinal diseases (IRDs) are a diverse group of disorders characterized by progressive vision loss caused by photoreceptor cell dysfunction. The eye has always been an attractive organ for the development of novel therapies due to its independent access to the systemic pathway.
View Article and Find Full Text PDFEfficacy of adipose-derived mesenchymal stem cell therapy in the treatment of chronic micro- and macrovascular complications of diabetes.
Diabetes Obes Metab
March 2024
Department of Physiology, Medical University of Bialystok, Bialystok, Poland.
Article Synopsis
- * Adipose-derived mesenchymal stem cells (ADMSCs) are promising for treating diabetes complications due to their abundance, easy collection, and the various beneficial substances they release that can aid in healing and regeneration.
- * While preclinical studies have shown positive effects of ADMSC therapy in improving diabetes-related issues, there are still barriers to its application in human treatments, though several clinical trials are currently exploring their use, especially for diabetic foot ulcers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!